Companies in this industry engage in biotechnology research and development to produce processes or prototypes of new or genetically altered products using microorganisms and cellular and biomolecular techniques. Major US organizations engaged in biotechnology research include the Howard Hughes Medical Institute (HHMI), the Jackson Laboratory (JAX), and Scripps Research; institutes affiliated with government research agencies and major universities, such as the Whitehead Institute (MIT); and the research departments of large biotechnology companies such as Amgen, Genentech, and Sanofi Genzyme. Large organizations based outside the US include Babraham Institute and the Wellcome Sanger Institute (both based in the UK); Hong Kong Institute of Biotechnology (HKIB) (Hong Kong); and Flanders Institute for Biotechnology (VIB) (Belgium).
COMPETITIVE LANDSCAPE
Demand for biotechnology research in the fields of agriculture (food and biofuel), medicine, and science is driven by the global need to produce more food for a rapidly expanding population, the need for alternatives to oil and gas, and scientists' desire to find solutions for complex scientific and medical issues. The profitability of individual companies depends on the discovery of potentially marketable new products. Large companies enjoy economies of scale in purchasing expensive equipment. But because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research. The US industry is concentrated: the 50 largest firms account for about 60% of revenue.